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Abstract
Glomus tumors are benign hyperplasia of glomus bodies, and they are rarely found in the head and neck. The middle ear
is an exceptionally rare site for a true glomus tumor, and there are only three previously reported cases in this location.
Glomus tumors are etiologically different than glomus tympanicum, which are paragangliomas of the middle ear that are
often mistakenly referred to as “glomus tumors.” This is a common misconception due to the “glomus” misnomer. We
report a case of a patient diagnosed with a middle ear glomangioma after initially presenting to our clinic with tinnitus and
hearing loss. The mass was surgically removed through a transcanal approach with carbon dioxide laser and sharp dissection.
Literature review is also reported and revealed similar presentations in patients with middle ear glomangiomas.
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Introduction
Glomus bodies are neuromyocutaneous structures that are
important for regulating temperature via arteriovenous
shunting of blood.1 Benign hyperplasia of glomus bodies
results in glomus tumors, which are rare soft tissue tumors
usually found in the extremities. However, glomus tumors
have been described in almost every location and can even
occur in areas that do not contain glomus bodies.2 It is important to distinguish them from paragangliomas, which are
more common in the head and neck and often erroneously
referred to as “glomus tumors.” True glomus tumors can be
further categorized based on their histopathology into solid
glomus tumors, glomangiomas, and glomangiomyomas.
Glomangiomas are the second most common variant and are
so named due to their prominence of vascularity.1,3
Glomus tumors of any subtype are especially rare occurrences in the head and neck. They occur most often as nasal
glomangiomas, of which there have only been 33 cases
described in the literature.4,5 The middle ear is an even more
exceptionally rare location for these tumors with only three
cases reported in the literature to date.6 We report a case of a
middle ear glomangioma, which is the fourth reported case
of a glomangioma in this location.

Case report
A 64-year-old female with history of hypertension and headaches was referred to our clinic after 2 years of gradually

worsening pulsatile tinnitus and feeling of ear fullness that
was refractory to medical management. She had a new onset
of left otalgia, but otherwise denied otorrhea, acute change in
hearing, or any previous injuries or surgeries to either ear. On
exam, the left tympanic membrane was intact, but there was
a red mass deep to the posteroinferior quadrant. The external
auditory canal was unremarkable. On audiologic evaluation,
she was found to have mild to moderate mixed hearing loss
(sensorineural component was mild) in the left ear, with type
A tympanogram.
Computed tomography (CT) of the temporal bones from
outside hospital demonstrated an enhancing soft tissue
mass arising from the hypotympanum, adjacent to the inferior tympanic canaliculus (Figure 1). Based on exam and
imaging findings, the mass was suspected to be a glomus
tympanicum. Urinary metanephrines were collected and
were negative. CT angiogram identified a tumor blush in
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Figure 1. Coronal (left) and axial (right) images from CT temporal bone without contrast demonstrate enhancing soft tissue mass
arising from the hypotympanum, adjacent to the inferior tympanic canaliculus.

Figure 2. (a, b) Well-circumscribed lesion composed of small capillaries with areas containing discrete nests of blast cells with monomorphic
round nuclei. (c) There is significant vascularity throughout the tumor representing a glomangioma variant of the glomus tumor.

left tympanic region supplied by left ascending pharyngeal
artery.
The patient underwent a transcanal excision of the tumor
with carbon dioxide (CO2) laser using the Omni guide system 29 days after neurotology visit. The tumor was identified
extending into the mesotympanum and was attached to the

inferior promontory and hypotympanum. This was removed
completely with a combination of CO2 laser and sharp dissection. There was no ossicular erosion identified, and normal movement of the ossicles was noted. No complications
were observed postoperatively. Surgical specimen was sent
to the lab, and histopathology is shown in Figure 2. Final
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Table 1. All reported cases of glomangiomas in the middle ear.
Pt.#

Year (Ref. #)

Age/sex

Middle ear

Aditus ad antrum

Mastoid air cells

Hearing loss

Tinnitus

EAC

1
2
3
4a

20047
20128
20186
2021

62/F
54/F
36/F
64/F

Y
Y
Y
Y

Y
Y
Y
N

Y
Y
Y
N

Y
Y
Y
Y

Y
Y
NR
Y

Y
NR
NR
NR

F: female; EAC: external auditory canal; Y: yes; N: no; NR: not reported; Ref: reference.
a
Present case.

report was a glomangioma variant of a glomus tumor.
Immunohistochemistry was not performed due to the characteristic appearance of the specimen.
The patient followed up 1 month after procedure. She
still had occasional pulsatile tinnitus, but she was otherwise
doing well. Otomicroscopy revealed appropriate healing
without concerns for recurrent glomus tumor, granulation
tissue, tympanic membrane perforation, or purulent
otorrhea.

Discussion
Glomus tumors result from hyperplasia of glomus bodies
and the vast majority are benign, showing no abnormal
mitotic figures. Complete excision is considered to be curative. However, the tumors are not encapsulated, and it is possible to have tumor recurrence if not completely excised.6
True glomus tumors are rare in the head and neck. This is the
fourth reported case of a middle ear glomangioma, all of
which have occurred in females and been further classified
as glomangiomas.6–8 Our patient presented similarly to previous cases with pulsatile tinnitus, ear fullness, and objective
hearing loss (see Table 1). She later developed otalgia.
Pulsatile tinnitus and hearing loss are also the usual presentation of glomus tympanicum tumors,9 which are similar to
the four reported cases of the middle ear glomangiomas.
Glomus tympanicum is a benign highly vascular extra-adrenal paraganglioma9 and is the most common primary neoplasm of the middle ear.10 Since the name of these neoplasms
is a misnomer, they are often mistakenly referred to as “glomus tumors,” even though they have different cell origin and
etiologies than true glomus tumors. Other head and neck
paragangliomas also contain this misnomer, as glomus vagale
and glomus jugulare tumors are also paragangliomas.
We initially suspected our patient’s mass to be a
glomus tympanicum tumor and further evaluated it with laboratory evaluation for metanephrines, which were negative.
Only 1%–8% of extra-adrenal paragangliomas secrete
catecholamines,11,12 so negative laboratory evaluation does
not rule out glomus tympanicum. True glomus tumors are not
of neuroendocrine origin and so will not secrete catecholamines; thus, the negative lab workup is consistent retrospectively as well. Even though lab exam is not sensitive for
paragangliomas, it is always recommended to evaluate a possible glomus tumor with urinary and/or plasma metanephrines

because of potential complications with unexpected catecholamine release intraoperatively with tumor dissection.13,14
Due to the overlap in clinical presentation, pathology and
immunohistochemistry are the only way to truly differentiate
glomus tumors like glomangiomas from glomus tympanicum tumors. Unlike glomus tympanicum tumors, glomangiomas stain negatively for neuroendocrine markers such as
chromogranin A, S100, and synaptophysin.6–8 Instead,
pathology shows positive expression of smooth muscle actin
(SMA).7,8 In our case, immunochemistry was not performed
due to the characteristic appearance of the specimen.

Conclusion
Literature review revealed three total cases of patients presenting a middle ear mass that was later diagnosed as a glomangioma. Our case establishes a fourth occurrence of such
tumor. Consistent symptoms of these tumors are tinnitus, ear
fullness, and objective hearing loss. Although rare, increasing case reports of this entity suggest that glomangiomas
should be included on the wide differential diagnosis when a
patient presents with a middle ear mass behind an intact tympanic membrane.
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